Compare Stocks

The Morgan Creek-Exos Active SPAC Arbitrage ETF (CSH) is an exchange-traded fund that mostly invests in extended market equity. The fund is actively managed to provide exposure to US-listed pre-combination special purpose acquisition companies (SPACs) through the use of common stock, warrants and rights. Positions will generally be in small- and mid-cap companies. CSH was launched on Feb 1, 2022 and is managed by Morgan Creek.

Era Group Inc. provides helicopter transportation services primarily to the oil and gas exploration, development, and production companies. Its helicopter services include emergency response search and rescue; and other services, as well as utility services to support firefighting, mining, power line, and pipeline survey activities. The company also leases helicopters to third parties and foreign affiliates. As of December 31, 2018, it owned a total of 108 helicopters, including 9 heavy helicopters, 46 medium helicopters, 23 light twin engine helicopters, and 30 light single engine helicopters. The company operates in the United States, Latin America and the Caribbean, Europe, and Asia. Era Group Inc. was founded in 1948 and is based in Houston, Texas.

Maverix Metals Inc., together with its subsidiaries, operates as a precious metals royalty and streaming company in Canada. The company explores for gold, silver, lead, zinc, copper, nickel, and other metals. It has a portfolio of over 100 royalties and streams in the Americas and Australia. The company was incorporated in 2016 and is headquartered in Vancouver, Canada.

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.